{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-015622","form_type":"8-K","ticker":"AVBP","cik":"0001868279","company_name":"ArriVent BioPharma, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.185106+00:00","generated_at":"2026-05-30T00:38:07.076987+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ArriVent reports Q3 2024 cash of $282.9M, net loss $59.9M; firmonertinib clinical progress highlighted","bullets":["Cash and cash equivalents $282.9M as of Sept 30, 2024; expected to fund operations into 2026.","Net loss $59.9M for nine months ended Sept 30, 2024; R&D expenses $58.9M, G&A $11.8M.","Positive interim firmonertinib data in EGFR PACC mutant NSCLC presented at WCLC 2024 with CNS activity.","Phase 3 FURVENT trial top-line data for firmonertinib in EGFR exon 20 NSCLC expected in 2025.","Dose expansion for firmonertinib plus SHP2 inhibitor expected in Q4 2024; ADC candidate selection by early 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-015622","json":"https://secwatch.observer/filing/0001558370-24-015622.json","markdown":"https://secwatch.observer/filing/0001558370-24-015622.md","text":"https://secwatch.observer/filing/0001558370-24-015622.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1868279/000155837024015622/0001558370-24-015622-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1868279/000155837024015622/avbp-20241114x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:38:07.076987+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}